Wegovy 1.7 mg 1 Prefilled Pen 1.5ml

Product Overview

Wegovy 1.7 mg Prefilled Pen is a prescription medication designed for chronic weight management in adults. This product is widely available on leading e-commerce platforms such as , , and .

It is used in conjunction with a reduced-calorie diet and increased physical activity.

This medication is intended for individuals with a body mass index (BMI) of 30 kg/m² or greater (obesity) or a BMI of 27 kg/m² or greater (overweight) with at least one weight-related comorbid condition such as high blood pressure, type 2 diabetes, or high cholesterol.

Wegovy offers a convenient weekly dosing schedule.

Benefits of Use

Wegovy 1.7 mg provides significant benefits for individuals seeking effective weight loss and improved health outcomes:

• Aids in significant and sustained weight reduction.
• Helps reduce appetite and increase feelings of fullness.
• Contributes to better control of blood sugar levels in some individuals.
• Supports improvements in weight-related health conditions.

How to Use

Always follow your healthcare provider's instructions for using Wegovy 1.7 mg:

1. Administer Wegovy once a week, on the same day each week, at any time of day, with or without meals.
2. Inject the solution subcutaneously (under the skin) in your abdomen, thigh, or upper arm.
3. Rotate injection sites with each dose to prevent skin irritation.
4. Use a new needle for each injection and dispose of it properly in a sharps container.
5. Do not share your Wegovy pen with others, even if the needle is changed, as this poses a risk of infection.
6. If you miss a dose and the next scheduled dose is more than 2 days away, take the missed dose as soon as possible. If it is less than 2 days away, skip the missed dose and resume your regular schedule.

Caution & Warnings

Before using Wegovy, discuss all medical conditions with your doctor. Important warnings include:

• May cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). Do not use if you or your family have a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Risk of pancreatitis (inflammation of the pancreas). Seek immediate medical attention if you experience severe abdominal pain.
• May cause gallbladder problems, including gallstones.
• Risk of hypoglycemia (low blood sugar), especially when used with other diabetes medications.
• Acute kidney injury and worsening of chronic kidney failure have been reported.
• Serious allergic reactions may occur. Stop use and seek immediate medical help if you experience symptoms like swelling of the face, lips, tongue, or throat, or difficulty breathing.
• Do not use for type 1 diabetes.
• Not recommended for use in children under 18 years of age.
• Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Ingredients

Each 1.5 mL prefilled pen of Wegovy 1.7 mg contains:

• Active ingredient: Semaglutide 1.7 mg.
• Inactive ingredients: Disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment), water for injection.

Product Details

• Brand: Wegovy
• Manufacturer: Novo Nordisk
• Active Ingredient: Semaglutide
• Strength: 1.7 mg
• Dosage Form: Solution for Injection (Prefilled Pen)
• Package Size: 1 Prefilled Pen (1.5 mL)
• Administration Route: Subcutaneous
• Storage: Refer to packaging for specific storage instructions. Generally, store unopened in a refrigerator (2C to 8C).